Overview

The diagnosis, treatment and overall care needs of breast cancer patients becomes more complex every year due to innovative improvements in therapies, better screening processes, and multidisciplinary care models developing across the US. The indications for axillary node dissection continue to change. Immununotherapy with immune checkpoint blockade is achieving startling results in some patients. There are more options for molecular profiling of tumors, as well as more choices about systemic therapies and radiation therapy. There are more and more long term survivors who require careful management to maintain a high quality of life. Come listen, learn and actively participate in discussions regarding these topics and more.

Target Audience

Academic/Research, Diagnostic Radiology, Family Practice, General Practice, General Surgery, Internal Medicine, Nurse Practitioner, Nursing, Ob/Gyn, Oncology, Pathology, Pharmacist, Physical Therapy, Physician Assistant, Radiology

Objectives

1. Describe new data and discuss ongoing controversies in the management of breast cancer.
2. Apply evolving data to individualize breast cancer management.
3. Identify areas of controversy in neoadjuvant treatment of breast cancer.

Registration

Registration Form

Accreditation

The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Johns Hopkins University School of Medicine designates this live activity for a maximum of 11.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The Johns Hopkins University has approved this activity for 11.25 contact hours for non-physicians.

Brochure